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Material and Methods: 118 patients with FIGO IB2-IVA st. 
were treated with RT-CT radical (Tab A). Anti-EGFR 
monoclonal Ac.(clone H11 Ref. M-3363 -Dako). The 
Immunoreactivity was based on semiquantitative analysis 
scored as the % of stained cells. Moderate/high EGFR staining 
(>31 to ≥70%, respectively) were considered (+). Anti -COX-2 
monoclonal Ac. (clone CX-2949 Ref. M361 - Dako). 
Moderate/high COX-2 staining (>31 to ≥70%, respectively) 
were considered (+). Pelvic radiotherapy in 21 patients with 
RT-3D, dose 46 Gy. In 97 cases (82%) was extended to the 
para-aortics, dose 45 Gy. A single application of LDR BCT was 
delivered on 51 pts (43.5%). Isotope: Cs-137. Dose to point A: 
30 Gy. HDR BCT to 64 pts (54%) in 3 or 4 applications. 
Isotope: Ir-192; Microselectron®. Dose 30 Gy to point A (33 
pts) and a dose of 7 Gy to CTV/application (31 pts). CT: 
CDDP: 40 mg/m2/ iv weekly.  
 
Results: Mean time follow-up for 118 pts: 56.5 months ±DS 
10.5 (median 56). Mean time follow-up of lost pts (8): 48 
months ± DS 10.5 (median 46). Clinical characteristics and 
treatments in Tab nº1 and º2.  
 
 
 
EGFR: 33 pts without overexpression vs. 85 pts (72%) with 
overexpression. COX-2: 77 pts without overexpression vs 41 
(35%) with over-expression. 24% were EGFR/COX-2 (+), 58% 
were EGFR (+)/ COX-2 (-) or vice versa and 18% were EGFR/ 
COX-2 (-). 94 pts (80%) with CR, 22 pts with PR and 2 pts 
stabilisation. Actuarial OS at 3/5 yrs:79% (CI 95%:70-85) and 
77% (CI 95%:68-84). Actuarial DFS at 3/ 5 yrs:71% (CI 95%: 62-
78) for both. Actuarial PFFS at 3/5 yrs:81% (IC 95%: 72-87) for 
both. We observed 13 local failures, 4 regional failures, 6 
joint failures; 1 pure para-aortic failure, 9 exclusive 
metastasis to distance. We found that EGFR overexpression is 
age related >50 yrs old (p=0.01). The most advanced stages 
(III-IVA) are related to joint overexpression of both markers 
(p=0.02). Tab nº3 and º4 summarize our results.  
 
 
The EGFR overexpression or COX-2 or both together, did not 
reach significance in the univariate analysis for DFS and PPFS. 
 
Conclusion: We did not find an association between 
overexpression of EGFR and/or COX-2 regarding the DFS and 
PPFS, despite being described in literature that these 
markers play a role in tumoral biology and in its 
evolution.There is a need for homogeneous, prospective 
studies with a standardized determination for these markers. 
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Purpose or Objective: We previously reported that the 
disruption of MEK/ERK/c-Myc axis affects in vitro and in vivo 
growth, angiogenic signaling and radiosensitivity of the 
embryonal rhabdomyosarcoma (ERMS) cell lines. Herein, we 
investigated the role of c-Myc in vitro invasion, migration, 
neo-angiogenesis and radioresistance of ERMS cells.  
 
Material and Methods: RD and TE671 cells expressing the c-
Myc dominant negative MadMyc chimera protein or shRNA-c-
Myc were used. 
 
Results: c-Myc depletion affected ERMS cells in vitro 
migration and invasion abilities by reducing the sialylation 
levels of NCAM and decreasing the MMP-9, MMP-2 and u-PA 
gelatinolytic activity. Although c-Myc down-regulation 
affected HIF1-α, VEGF and TSP1 proteins expression, no 
effects were seen on in vitro neo-angiogenesis. Rapid, but 
not prolonged, c-Myc down-regulation radiosensitized ERMS 
cells by impairing the expression of DSB repair proteins such 
as RAD51 and DNA-PKcs but not Ku80. 
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Conclusion: Herein c-Myc acts as a key master regulator of in 
vitro migration, invasion and radioresistance. In fact, c-Myc 
depletion alone seems to be sufficient to block the in vitro 
pro-metastatic abilities and to radiosensitize ERMS cells. In 
addition, our data suggest c-Myc as important, but not 
essential, in controlling the molecular machinery responsible 
for cancer neo-angiogenesis. In conclusion these data 
strongly suggest that the targeting of c-Myc can be tested as 
a promising strategy for an anti-cancer therapy. 
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Purpose or Objective: To evaluate apoptotic pathways 
involved in prostate cancer treated with intraoperative 
radiotherapy (IORT) with 12 Gy, studying the effects on 
cancer cells, prostatic intraepithelial neoplasia (PIN) and 
normal cells 
 
Material and Methods: Since 2005, 111 patients treated at 
University Hospital of Novara, Italy with local advanced 
prostate adenocarcinoma were treated with radical 
prostatectomy and 12 Gy IORT followed by 50 Gy 
postoperative radiotherapy. In this setting, we selected a 
sample of 10 patients for a preliminary feasibility study. 
Selection criteria for this phase were: no neoadjuvant 
hormone therapy, Gleason score > 7. Proteins involved in the 
apoptotic cascade (Bax, Caspases -3 and -9) were studied 
before and after 12 Gy single shoot in neoplastic cells, high 
grade PIN areas and in normal prostate cells. 
Immunofluorescent detection of antigens (anti-Bax, anti-
caspases-3 and -9), were performed on bioptic sample and on 
surgical specimens 5-mm slices. On surgical specimens there 
were also detected Bcl-2, and ki-67 with immunoistochimical 
analysis. A count of positive spots for immunofluorescence 
(Bax+, Caspases-3 and -9+/all nuclei, 40x magnification) was 
performed on tumor cells, PIN, healthy tissue areas. Bax and 
caspases immunofluorescent positivity was compared in 
different areas and in neoplastic areas before and after 
single shoot high dose 
 
Results: A significant increase in Bax, Caspases-3 and -9 
expression was detected in tumor and PIN areas comparing 
IORT treated and untreated samples (p<0.05). After 12 Gy-
single dose, healthy areas expressed significantly lower level 
of Bax and caspases positive with respect to neoplastic cells 
(p<0.0001), while in PIN areas, Bax positive cells were 
significantly more present than in neoplastic areas 
(p=0.0001). Mean Bcl-2 in neoplastic cells is 17% (range: 1-
23), mean ki-67 in neoplastic area is 4.5% (range: 1-17). With 
multivariate analysis, we find that cancer cells with Ki-67 ≥ 
8% show a trend toward greater expression of Bax (p=0.0641) 
 
Conclusion: After 12 Gy irradiation, Bax and caspases 
resulted overexpressed in tumor and PIN cells, in particular in 
prostate cancer with higher proliferation index. PIN areas 
seem to be more radiosensitive than neoplastic areas and 
healthy cells do not activate apoptosis after single shoot, 
showing an intrinsic radioresistence. This preliminary study 
represents the basis for an extensive work in which we would 
correlated clinical parameters with pathology and apoptotic 
factors. In fact, the comprehension of these relationships 
could allow to better understand the mechanisms of high 
dose per fraction and, radioresistence in order to personalize 
treatments 
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Purpose or Objective: Purpose: Radiation treatment of 
tumor cells resulted in a reduction of endogenous ATP levels. 
Aim of this study was to elucidate the molecular scenario 
standing behind this observation. 
 
Material and Methods: Endogenous ATP-levels were 
dermined by ATP-ELISA. HIF1a, PDK1, LDH and PDH 
expressions were visualized by western blotting. Lactate 
production was quantified by lactate-assay. Cellular survival 
was proved by clonogenic survival assay. 
 
Results: Results: Ionizing radiation induced expression of Hif1 
alpha even at clinical relevant doses of 2 Gy. Hif1alpha 
induced activation of mitochondrial PDK1, which results in 
PDK1 dependent phosphorylation of pyruvate dehydrogenase 
(PDH). PDH is responsible for conversion of pyruvate to 
acetyl-CoA, which fuels the TCA cycle. Thus, irradiation 
blocks TCA cycle and mitochondrial activity. Simultaneously 
Hif1alpha induced expression and activity of lactate 
dehydrogenase (LDHA) to convert glucose to lactate. Indeed 
we observed a clear increase in lactate production in tumor 
cell lines in response to irradiation. Furthermore, inhibition 
of PDH activity was associated with mitophagy and ATP-
depletion, which explains the radiation induced ATP drop 
down. In addition, this radiogenic switch to lactate 
production reduced production of mitochondrial derived 
radicals and increased cellular radio-resistance. 
Pretreatment with the Hif1 alpha inhibitor BAY87-2243 
prevented the radiogenic switch to lactate metabolism and 
radio-sensitized the tumor cells. In addition, tumor cells are 
strictly dependent from high glucose supply after irradiation 
and can be radio-sensitized by blockage of radiogenic glucose 
uptake with glucose transporter SGLT inhibitor Phlorizin. 
 
Conclusion: In summary, we could show, that tumor cells 
switch in a Hif1 alpha dependent manner to anaerobe glucose 
metabolism to generate ATP, which renders cells radio-
resistant. Blockage of Hif1 alpha stabilization or blockage of 
glucose uptake radio-sensitized tumor cells.  
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Purpose or Objective: Phosphorylated histone H2AX (γH2AX) 
foci are well-known markers of DNA double-strand breaks in 
human cells. Spontaneous γH2AX foci form on unrepaired 
DNA double strand breaks, shortened telomeres and sites 
with altered chromatin conformation. The presence of such 
permanent γH2AX foci in cell is an important component of 
epigenetic background and potentially lead to the activation 
of DNA repair system. The objective of this study was to 
analyze the effects of spontaneous γH2AX level on radiation-
induced response in human somatic cells. 
 
Material and Methods: Spontaneous γH2AX foci and 
radiation-induced micronuclei were analyzed in peripheral 
blood lymphocytes of 54 healthy individuals after exposure to 
2 Gy ionizing radiation in vitro. Further, a transcriptome 
analysis was performed using gene expression microarrays in 
lymphocytes of two sub-groups of individuals: 1) 
